Quarterly report · Q3

Period2022-01-21 → 2022-10-20
Filed2022-12-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥124.6bn2022-01-21 → 2022-10-20Cons.Net sales
Revenue¥162.6bn2021-01-21 → 2022-01-20Cons.Net sales (5-year summary)
Revenue¥124.7bn2021-01-21 → 2021-10-20Cons.Net sales
Operating income¥2.3bn2022-01-21 → 2022-10-20Cons.Operating income
Operating income¥5.3bn2021-01-21 → 2021-10-20Cons.Operating income
Ordinary income¥2.6bn2022-01-21 → 2022-10-20Cons.Ordinary income
Ordinary income¥5.7bn2021-01-21 → 2022-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.0bn2021-01-21 → 2021-10-20Cons.Ordinary income
Profit before tax¥2.9bn2022-01-21 → 2022-10-20Cons.Income before income taxes
Profit before tax¥6.0bn2021-01-21 → 2021-10-20Cons.Income before income taxes
Net income (owners)¥736m2022-01-21 → 2022-10-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2021-01-21 → 2022-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.9bn2021-01-21 → 2021-10-20Cons.Profit loss attributable to owners of parent
Net income¥725m2022-01-21 → 2022-10-20Cons.Profit loss
Net income¥3.9bn2021-01-21 → 2021-10-20Cons.Profit loss
Total assets¥167.8bnat 2022-10-20Cons.Assets
Total assets¥159.0bnat 2022-01-20Cons.Assets
Total assets¥168.8bnat 2021-10-20Cons.Total assets (5-year summary)
Total liabilities¥83.7bnat 2022-10-20Cons.Liabilities
Total liabilities¥75.7bnat 2022-01-20Cons.Liabilities
Net assets / equity¥84.1bnat 2022-10-20Cons.Net assets
Net assets / equity¥83.3bnat 2022-01-20Cons.Net assets
Net assets / equity¥86.5bnat 2021-10-20Cons.Net assets (5-year summary)
Cash and deposits¥28.9bnat 2022-10-20Cons.Cash and deposits
Cash and deposits¥27.6bnat 2022-01-20Cons.Cash and deposits
EPS (basic)¥46.992022-01-21 → 2022-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥102.452022-07-21 → 2022-10-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥254.22021-01-21 → 2022-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥250.152021-01-21 → 2021-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥136.762021-07-21 → 2021-10-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio49.9%at 2022-10-20Cons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2022-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-10-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-10-20−¥1.0bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥83.6bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥83.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥24m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥2.8bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-10-20−¥380m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥6m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥1.3bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20−¥752m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥9.7bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥9.2bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥490m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥377m
—segment totalrevenue2022-01-21 → 2022-10-20¥125.2bn
—segment totalrevenue external2022-01-21 → 2022-10-20¥124.6bn
—segment totalrevenue intersegment2022-01-21 → 2022-10-20¥521m
—segment totalsegment profit2022-01-21 → 2022-10-20¥3.3bn
Reconciling Itemsreconcilingrevenue2021-01-21 → 2021-10-20−¥463m
Reconciling Itemsreconcilingrevenue intersegment2021-01-21 → 2021-10-20−¥463m
Reconciling Itemsreconcilingsegment profit2021-01-21 → 2021-10-20−¥1.1bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥89.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥89.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2021-01-21 → 2021-10-20¥37m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-10-20¥5.9bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2021-01-21 → 2021-10-20−¥463m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥17.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥17.3bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2021-01-21 → 2021-10-20¥15m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2021-01-21 → 2021-10-20¥1.3bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥9.7bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥9.7bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-10-20−¥384m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥8.5bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥8.1bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2021-01-21 → 2021-10-20¥409m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2021-01-21 → 2021-10-20¥71m
—segment totalrevenue2021-01-21 → 2021-10-20¥125.1bn
—segment totalrevenue external2021-01-21 → 2021-10-20¥124.7bn
—segment totalrevenue intersegment2021-01-21 → 2021-10-20¥463m
—segment totalsegment profit2021-01-21 → 2021-10-20¥6.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 391
ItemContextValueUnit
Noncurrent assetsCurrentQuarterInstant79983000000JPY
AssetsPrior1YearInstant158984000000JPY
AssetsCurrentQuarterInstant167794000000JPY
Notes and accounts payable tradePrior1YearInstant17148000000JPY
Notes and accounts payable tradeCurrentQuarterInstant24467000000JPY
Current portion of long term loans payablePrior1YearInstant3748000000JPY
Current portion of long term loans payableCurrentQuarterInstant3889000000JPY
Accounts payable otherPrior1YearInstant10919000000JPY
Accounts payable otherCurrentQuarterInstant10625000000JPY
Income taxes payablePrior1YearInstant1796000000JPY
Income taxes payableCurrentQuarterInstant1498000000JPY
Provision for bonusesPrior1YearInstant1230000000JPY
Provision for bonusesCurrentQuarterInstant1975000000JPY
Provision for directors bonusesPrior1YearInstant-JPY
Provision for directors bonusesCurrentQuarterInstant32000000JPY
Other clPrior1YearInstant3919000000JPY
Other clCurrentQuarterInstant4088000000JPY
Current liabilitiesPrior1YearInstant38764000000JPY
Current liabilitiesCurrentQuarterInstant46577000000JPY
Bonds payablePrior1YearInstant20000000000JPY
Bonds payableCurrentQuarterInstant20000000000JPY
Long term loans payablePrior1YearInstant7265000000JPY
Long term loans payableCurrentQuarterInstant8121000000JPY
Provision for directors retirement benefitsPrior1YearInstant169000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant173000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant131000000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant125000000JPY
Net defined benefit liabilityPrior1YearInstant558000000JPY
Net defined benefit liabilityCurrentQuarterInstant294000000JPY
Other nclPrior1YearInstant8833000000JPY
Other nclCurrentQuarterInstant8389000000JPY
Noncurrent liabilitiesPrior1YearInstant36958000000JPY
Noncurrent liabilitiesCurrentQuarterInstant37103000000JPY
LiabilitiesPrior1YearInstant75722000000JPY
LiabilitiesCurrentQuarterInstant83681000000JPY
Capital stockPrior1YearInstant1924000000JPY
Capital stockCurrentQuarterInstant1924000000JPY
Capital surplusPrior1YearInstant374000000JPY
Capital surplusCurrentQuarterInstant375000000JPY
Retained earningsPrior1YearInstant90715000000JPY
Retained earningsCurrentQuarterInstant87955000000JPY
Treasury stockPrior1YearInstant-4231000000JPY
Treasury stockCurrentQuarterInstant-4106000000JPY
Shareholders equityPrior1YearInstant88781000000JPY
Shareholders equityCurrentQuarterInstant86148000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant6798000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant4127000000JPY
Deferred gains or losses on hedgesPrior1YearInstant484000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant1400000000JPY
Foreign currency translation adjustmentPrior1YearInstant-13543000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-01-20pass rounding
balance sheet identityconsolidated 2022-10-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-01-20pass
statement vs summary · net assetsconsolidated 2022-10-20pass
statement vs summary · net income attributable to parentconsolidated 2021-01-21/2021-10-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-10-20pass
statement vs summary · revenueconsolidated 2021-01-21/2021-10-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-10-20pass
statement vs summary · total assetsconsolidated 2022-01-20pass
statement vs summary · total assetsconsolidated 2022-10-20pass